Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Not Applicable

Completed

• Conditions: Breast Cancer

• Registration Number: NCT01428739
• Lead Sponsor: AHS Cancer Control Alberta

Brief Summary

Correlation between MRS and Tumor Response Therapy in Breast Cancer.

Detailed Description

Correlation between MRS (Magnetic Resonance Spectroscopy and Tumor Response to Radiation in Breast Cancer

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2010-10-21
• Study First Submitted QC: 2011-09-02
• Study First Posted: 2011-09-05
• Primary Completion: 2014-09
• Study Completion: 2014-09
• Status Verified: 2014-10
• Last Update Submitted: 2017-01-23
• Last Update Posted: 2017-01-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Histologically confirmed diagnosed Breast cancer
• Patient is 18 years or older
• Karnofsky performance score > 70
• No previously irradiated or recurrent breast cancer
• No contraindication to MRS/MRI
• Signed informed consent.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
MRS Correlation with Treatment Response	Up to One Year	measuring choline, water and fat levels by proton magnetic resonance spectroscopy in breast tumors in response to treatment

Secondary Outcome Measures

Name	Time	Method
Correlation with Tumor Stage	Up to One year

Trial Locations

Locations (1)

Cross Cancer Institute; 🇨🇦 Edmonton, Alberta, Canada